Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Beckley Psytech Limited (United Kingdom)
Homepage:
beckleypsytech.com
Alternate name:
Beckley Psytech Limited
ROR:
03k0v1a27
OpenAlex ID:
I4405267613
A narrative synthesis of research with 5-MeO-DMT
2021
·
Anna O Ermakova
, Fiona Dunbar
, et al.
·
Journal of Psychopharmacology
·
100
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healthy participants
2024
·
James Jonathan Rucker
, Claire Roberts
, et al.
·
Journal of Psychopharmacology
·
49
PDF
Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study
2024
·
James Rucker
, Matt Butler
, et al.
·
Headache The Journal of Head and Face Pain
·
16
PDF
5‐Methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial
2025
·
John Marsden
, Michael Kelleher
, et al.
·
Addiction
·
9
PDF
Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults
2025
·
Anna O. Ermakova
, Fiona Dunbar
, et al.
·
Scientific Reports
·
8
PDF
A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine) in patients with treatment-resistant depression
2026
·
Claire Roberts
, Mathieu Seynaeve
, et al.
·
Journal of Psychopharmacology
·
6
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial
2026
·
Mathieu Seynaeve
, Fiona Dunbar
, et al.
·
CNS Drugs
·
3
PDF
Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine
2026
·
Burton J. Tabaac
, Kenneth Shinozuka
, et al.
·
American Journal of Therapeutics
·
3
181. Rapid, Sustained and Meaningful Antidepressant Effect of Intranasal BPL-003 (5-Methoxy-N,N-Dimethyltryptamine) in Treatment-Resistant Patients
2025
·
Fiona Dunbar
, Mathieu Seynaeve
, et al.
·
Biological Psychiatry
·
2
Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial
2026
·
David Feifel
, Mathieu Seynaeve
, et al.
·
JAMA
·
1
5-Methoxy-N,N-Dimethyltryptamine: Functional Safety Pharmacology and Video-EEG Assessment of a Short-Acting Serotonergic Psychedelic in Beagle Canines
2026
·
Amir Lotfi
, Samantha Sparapani
, et al.
·
International Journal of Toxicology
·
1
The efficacy of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) on anhedonia in patients with treatment resistant depression: a phase 2a open label study
2026
·
C. Hindocha
, S. McGuigan
, et al.
·
Neuroscience Applied
·
1
Rapid antidepressant effect of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in treatment-resistant patients: a phase 2a open label study
2024
·
C. Roberts
, M. Seynaeve
, et al.
·
Neuroscience Applied
·
1
105. Intranasal 5-MeO-DMT: Safety, PK and Effect on Altered States of Consciousness in Healthy Volunteers
2023
·
James Rucker
, Mathieu Seynaeve
, et al.
·
Biological Psychiatry
·
1
Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network
2026
·
Mathieu Seynaeve
, Leonie Schneider
, et al.
·
Frontiers in Psychiatry
PDF
Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy
2026
·
Mathieu Seynaeve
, Fiona Dunbar
, et al.
·
Addiction
Reclaiming the Matrix: The Importance of the Social Environment in Psychedelic-Assisted Therapy
2026
·
Jacobs, Edward
, Wells, Hattie
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Plain Language Summary Publication: Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: Results from an open‐label phase Ib ascending dose study
2024
·
James Rucker
, Matt Butler
, et al.
·
Headache The Journal of Head and Face Pain
Blinding in psychedelic studies: comparison of placebo and sub-perceptual dose of intranasal 5-Methoxy-N,N-dimethyltryptamine in healthy volunteers
2024
·
C. Hindocha
, M. Seynaeve
, et al.
·
Neuroscience Applied
Using psychedelics to mitigate Treatment Resistant Depression
2023
·
Cosmo Feilding-Mellen
·
Open Access Government
PDF
Phase 1 study results on the effects of 5-MeO-DMT benzoate on facial emotion processing in psychedelic-naïve healthy subjects
2023
·
A. Malik
, S.N. Millard
, et al.
·
Neuroscience Applied
Intranasal 5-methoxy-N,N-dimethyltryptamine safety, pharmacokinetics and psychedelic effects in healthy volunteers
2023
·
C. Roberts
, M. Seynaeve
, et al.
·
Neuroscience Applied
Show more works
View as search
Works count:
22
Citation count:
201
Year
Topic
Type